| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad551e7d78a9193cc2abbb644ad8a70f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2869a9111cb992cfaa4799bf131fa24d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5a7b1d92951443d774c971ac309ea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c649f06f7fd416adcdd4668af7696b12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22e891fd25cc2fb0e07fe045428e7539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8222d9237bdd865c5f647d7b742e9246 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47 |
| filingDate |
2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86abb698fdda4310cd48867c81c043fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a9d96d758c7a013cf3c523eeeb091c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1633265d93b49f167d18a2159f373086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543b0948188fdbaaa12dca5446d27fbf |
| publicationDate |
2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006090289-A2 |
| titleOfInvention |
Compounds for reducing aggregation of amyloid beta-peptide |
| abstract |
Compounds are disclosed that can inhibit the loss of α-helical conformation of an Aβ peptide. Methods of testing such compounds are disclosed as are methods of using the compounds to treat or prevent Alzheimer's disease and related disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015107170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1337855-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1337855-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9580460-B2 |
| priorityDate |
2005-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |